Dr. Lal PathLabs Limited (LALPATHLAB.NS)
NSE · INR · Healthcare · Diagnostics & Research
₹1,901.80 (+2.49%) as of
Key statistics
- Market cap
- 318.00B
- P/E (TTM)
- 58.70
- Forward P/E
- 43.34
- EPS (TTM)
- 32.40
- Dividend yield
- 1.08%
- 52-week range
- 1,272.60 – 2,038.60
- Beta
- 0.16
- Revenue (TTM)
- 28.91B
- Profit margin
- 18.75%
- Analyst target
- ₹2,018.08
- Volume
- 273.79k
About Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Gurugram, India
- Employees
- 5,206
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.